| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.ANTIVIRAL.2017.10.002 |
| P698 | PubMed publication ID | 28986103 |
| P50 | author | Aeron C. Hurt | Q42216629 |
| P2093 | author name string | Ding Yuan Oh | |
| Danielle Tilmanis | |||
| Jean-Francois Rossignol | |||
| Carel van Baalen | |||
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2017-10-03 | |
| P1433 | published in | Antiviral Research | Q4775352 |
| P1476 | title | The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide |
| Q56996774 | Advancements in Host-Based Interventions for Influenza Treatment |
| Q89795210 | Antivirals in medical biodefense |
| Q63246314 | Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy |
| Q98160225 | Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19? |
| Q92732609 | Intense interseasonal influenza outbreaks, Australia, 2018/19 |
| Q66679577 | Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections |
| Q95651180 | Prioritisation of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics |
| Q47547816 | Protein Disulfide Isomerases as potential therapeutic targets for Influenza A and B Viruses |
| Q89965550 | Respiratory Barrier as a Safeguard and Regulator of Defense Against Influenza A Virus and Streptococcus pneumoniae |
| Q60958294 | Respiratory Viral Infections in Patients With Cancer or Undergoing Hematopoietic Cell Transplant |
| Q60046097 | Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil |
| Q92025479 | Thiazolides promote G1 cell cycle arrest in colorectal cancer cells by targeting the mitochondrial respiratory chain |
Search more.